Salix Pharmaceuticals (SLXP), which announced its tax inversion merger last month, will be among several IBD 50 drug stocks to report earnings this week. In July, Salix announced plans to merge with Italy’s Cosmo Pharmaceuticals’ Irish subsidiary, Cosmo Technologies. The new headquarters will be in Ireland, which boasts lower taxes than the U.S. Both drug companies focus on finding treatments for gastrointestinal diseases. Inversions have been
Twitter (TWTR) shares soared 29% late Tuesday as the short-messaging site reported strong user growth, another quarter of accelerating, triple-digit revenue growth and a surprise earnings. The good momentum from Twitter could be a good sign for online review site Yelp (YELP), which is expected to report quarterly results Wednesday, and professional networker LinkedIn (LNKD), slated to announce results Thursday. But while Twitter gave hope that
While investors tend to focus on the latest quarter, great stock winners usually have superior long-term earnings and sales growth. IBD’s Top Fundamentals Screen of the Day requires minimum 3-year growth rates of 25% for EPS and sales. The current list’s three Chinese-based companies do much better than that. YY Inc. (YY) is a social media platform the lets users take part in group voice or video activities, from online karaoke to gaming to